A new approach to managing high blood pressure

Collaboration Oriented Approach to Controlling High Blood Pressure

Not applicable Interventional Oregon Health and Science University · NCT06124716

This study is testing a new app called COACH to see if it can help adults with high blood pressure manage their condition better by tracking their readings and making decisions with their doctors.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment550 (estimated)
Ages18 Years to 100 Years
SexAll
SponsorOregon Health and Science University Academic / other
Locations3 sites (Columbia, Missouri and 2 other locations)
Trial IDNCT06124716 on ClinicalTrials.gov

What this trial studies

This study evaluates the effectiveness of a clinical decision support app called COACH, designed to help patients manage their high blood pressure through self-monitoring and shared decision-making. The app integrates home blood pressure data into electronic health records and utilizes behavioral economics principles to enhance patient engagement. Conducted in multiple primary care settings, the study aims to improve blood pressure control among adults with hypertension and multiple chronic conditions. By implementing this tool across various health systems, the study seeks to address the challenges of managing hypertension in a patient-centered manner.

Who should consider this trial

Good fit: Ideal candidates include adults aged 18-100 with high blood pressure who have been seen in a participating primary care clinic within the last year.

Not a fit: Patients who may not benefit include those with severe cognitive impairment, end-stage renal disease, or those for whom tight blood pressure control poses greater risks.

Why it matters

Potential benefit: If successful, this approach could significantly improve blood pressure management and reduce the risk of heart attacks and strokes for patients.

How similar studies have performed: Other studies have shown promise with similar patient-centered approaches to hypertension management, indicating potential for success in this novel application.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients aged 18-100 years old
* Patient receives care at a participating primary care clinic and has been seen in the last year
* Patient has high BP, defined as an average of 4 BPs \> 140 systolic or \> 90 diastolic (clinic) or \> 135 OR \> 85 (home)
* Patient is enrolled in online health portal
* Patient can communicate in English
* Patient has been recommended by their physician who thinks the patient would benefit from a home blood pressure monitoring program.

Exclusion Criteria:

* Patient is pregnant at the time of consent
* Patient who, in the opinion of the primary care clinician, has severe cognitive impairment
* Patient is on hospice care and/or has a life expectancy of less than 2 years
* Patient has end stage renal disease
* Patient for whom tight blood pressure control presents a greater risk, such as those with a history of adverse events from hypertension treatment (falls, dizziness, electrolyte disturbances, hypotension, active heart failure)
* Patient has any other disease or disorder that in the opinion of the investigator or the patient's primary care clinician, could put participants at risk and affect trial results, or hinder participation will exclude them from participating

Where this trial is running

Columbia, Missouri and 2 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions HypertensionMultiple Chronic ConditionsPragmatic trialPrimary careClinical decision support
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.